0001104659-17-006179.txt : 20170202 0001104659-17-006179.hdr.sgml : 20170202 20170202170359 ACCESSION NUMBER: 0001104659-17-006179 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170201 FILED AS OF DATE: 20170202 DATE AS OF CHANGE: 20170202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1030 MASSACHUSETTS AVE. CITY: CAMBRIDGE STATE: MA ZIP: 02138 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 1030 MASSACHUSETTS AVE. CITY: CAMBRIDGE STATE: MA ZIP: 02138 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KARSEN PERRY A CENTRAL INDEX KEY: 0001260573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 17569147 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 a4.xml 4 X0306 4 2017-02-01 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001260573 KARSEN PERRY A C/O JOUNCE THERAPEUTICS, INC. 1030 MASSACHUSETTS AVENUE CAMBRIDGE MA 02138 1 0 0 0 Common Stock 2017-02-01 4 P 0 5000 16.00 A 5000 D /s/ Anna L. Barry, Attorney-in-fact 2017-02-02